Rapid Micro Biosystems Inc expected to post a loss of 29 cents a share - Earnings Preview

Rapid Micro Biosystems

01/05/2024 15:06

* Rapid Micro Biosystems Inc  RPID.OQ   RPID.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 3 for the period ending March 31 2024
    * The Lowell Massachusetts-based  company is expected to
report a
9.2% increase in revenue to $5.5 million from $5.04 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Rapid Micro Biosystems
Inc is
for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.25​, above​ its last closing price
of $0.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.30       -0.30      -0.26     Beat    13.3
 Sep. 30 2023  -0.30       -0.31      -0.31     Met     -1.1
 Jun. 30 2023  -0.35       -0.35      -0.33     Beat    5.7​
 Mar. 31 2023  -0.37       -0.36      -0.32     Beat    12.3
 ​​Dec.        -0.34       -0.36      -0.39     Missed  -8.3
 31 2022                                                
 Sep. 30 2022  -0.37       -0.37      -0.38     Missed  -3.6​
 Jun. 30 2022  -0.33       -0.32      -0.31     Beat    2.4
 Mar. 31 2022  -0.34       -0.33      -0.35     Missed  -4.5
 This summary was machine generated May 1 at 14:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)